NCT03102125View on ClinicalTrials.gov

Allograft Dysfunction in Heart Transplant

PHASE4RecruitingINTERVENTIONAL

Enrollment

376

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

December 1, 2025

Study Completion Date

December 2, 2025

Conditions

Heart Transplant Failure and Rejection

Interventions

DRUG

Regadenoson

For use in stress myocardial perfusion imaging.

Trial Locations (1)

92037

RECRUITING

UC San Diego, La Jolla

All Listed Sponsors

lead

Paul Kim

OTHER